Trade

with

Pfizer Inc
(NYSE: PFE)
US Markets Closed
AdChoices
27.93
+0.10
+0.36%
After Hours :
27.96
+0.03
+0.11%

Open

27.87

Previous Close

27.83

Volume (Avg)

38.93M (24.31M)

Day's Range

27.60-27.97

52Wk Range

27.51-32.96

Market Cap.

177.10B

Dividend Rate (Yield )

1.04 (3.65%)

Beta

0.67

Shares Outstanding

6.34B

P/E Ratio (EPS)

17.61 (1.59)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Drug Manufacturers – Major
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 51.58B

    • Net Income

    • 22.00B

    • Market Cap.

    • 177.10B

    • Enterprise Value

    • 180.91B

    • Net Profit Margin %

    • 20.66

    • PEG (Price/Earnings Growth) Ratio

    • 6.80

    • Beta

    • 0.67

    • Forward P/E

    • 12.61

    • Price/Sales

    • 3.63

    • Price/Book Value

    • 2.31

    • Price/Cash flow

    • 10.16

      • EBITDA

      • 23.54B

      • Return on Capital %

      • 5.91

      • Return on Equity %

      • 13.41

      • Return on Assets %

      • 5.91

      • Book Value/Share

      • 12.08

      • Shares Outstanding

      • 6.34B

      • Last Split Factor (Date)

      • 3:1 (7/1/1999)

      • Last Dividend (Ex-Date)

      • 0.26 (7/30/2014)

      • Dividend Declaration Date

      • 6/26/2014

      Analyst Recommendation
      10/17/2014
      Buy
        • 1 Year Price Target

        • 34.33

        • Credit Rating

        • AA

        • Analysts

        • 5

        • EPS Estimate

        • 1.96

        • Cashflow Estimate

        • 2.74

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -1.50

          • 0.89

          • Net Income

            YTD/YTD (last year)

          • 19.50

          • 7.80

          • Net Income

            Q/Q (last year)

          • -17.60

          • 4.50

          • Sales (Revenue)

            5-Year Annual Average

          • 1.33

          • 6.10

          • Net Income

            5-Year Annual Average

          • 7.20

          • 3.73

          • Dividends

            5-Year Annual Average

          • -5.59

          • 2.17

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 80.95

            • 69.92

            • Pre-Tax Margin

            • 26.79

            • 21.84

            • Net Profit Margin

            • 20.66

            • 18.37

            • Average Gross Margin

              5-Year Annual Average

            • 79.60

            • 71.90

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 21.10

            • 21.92

            • Average Net Profit Margin

              5-Year Annual Average

            • 22.30

            • 903.40B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.42

              • 0.32

              • Current Ratio

              • 2.66

              • 1.92

              • Quick Ratio

              • 2.03

              • 1.31

              • Interest Coverage

              • -

              • 17.64

              • Leverage Ratio

              • 2.25

              • 2.03

              • Book Value/Share

              • 12.08

              • 14.72

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 18.35

                • 21.74

                • P/E Ratio 5-Year High

                • 20.76

                • 193.96

                • P/E Ratio 5-Year Low

                • 8.82

                • 87.26

                • Price/Sales Ratio

                • 3.78

                • 3.68

                • Price/Book Value

                • 2.41

                • 3.66

                • Price/Cash Flow Ratio

                • 10.16

                • 13.76

                • Key Metrics

                • Company

                  • Shares Short

                    as of 9/30/2014

                  • 59.97M

                  • Short Ratio

                    as of 9/30/2014

                  • 2.66

                  • Short % of Float

                    as of 9/30/2014

                  • 0.94

                  • Shares Short

                    prior month

                  • 64.14M

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • 0.04

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • 62.98

                    • Dividend Date

                    • 6/26/2014

                    • Ex-Dividend Date

                    • 7/30/2014

                    • Last Split Factor

                      new per old

                    • 3:1

                    • Last Split Date

                    • 7/1/1999

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • 13.41

                        (15.70)

                      • 17.42

                        (18.66)

                      • Return on Assets %

                        (5-Year Average)

                      • 5.91

                        (6.90)

                      • 8.45

                        (8.77)

                      • Return on Capital %

                        (5-Year Average)

                      • 9.96

                        (11.60)

                      • 12.41

                        (13.18)

                      • Income/Employee

                      • 133.84k

                      • 90.07k

                      • Inventory Turnover

                      • 1.53

                      • 2.46

                      • Asset Turnover

                      • 0.29

                      • 0.46

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      15.72B
                      Operating Margin
                      30.47
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      10.16
                      Ownership

                      Institutional Ownership

                      73.65%

                      Top 10 Institutions

                      21.88%

                      Mutual Fund Ownership

                      35.80%

                      Float

                      99.98%

                      5% / Insider Ownership

                      0.23%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Total Stock Mkt Idx

                      •  

                        103,915,619

                      • 0.43

                      • 1.64

                      • Vanguard Five Hundred Index Fund

                      •  

                        65,828,953

                      • -0.36

                      • 1.04

                      • Vanguard Institutional Index Fund

                      •  

                        64,240,391

                      • -1.64

                      • 1.01

                      • SPDR® S&P 500 ETF

                      •  

                        63,189,476

                      • -1.09

                      • 0.94

                      • VA CollegeAmerica Income Fund of America

                      •  

                        56,230,000

                      • 1.35

                      • 0.89

                      • Franklin Income Fund

                      •  

                        45,000,000

                      • 12.50

                      • 0.71

                      • Vanguard Windsor™ II Fund

                      •  

                        44,416,681

                      • 5.66

                      • 0.70

                      • MFS® Value Fund

                      •  

                        32,765,471

                      • 0.00

                      • 0.52

                      • Vanguard Wellington™

                      •  

                        29,075,738

                      • 0.00

                      • 0.46

                      • Dodge & Cox Stock Fund

                      •  

                        29,071,064

                      • -3.36

                      • 0.46

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Group, Inc.

                      •  

                        327,984,566

                      • +1.72%

                      • 5.14

                      • State Street Corp

                      •  

                        267,871,506

                      • +0.79%

                      • 4.20

                      • BlackRock Fund Advisors

                      •  

                        203,559,323

                      • +3.99%

                      • 3.19

                      • Capital World Investors

                      •  

                        123,802,400

                      • +1.64%

                      • 1.94

                      • Wellington Management Company, LLP

                      •  

                        96,042,937

                      • +10.11%

                      • 1.51

                      • Northern Trust Investments, N.A.

                      •  

                        95,265,904

                      • -1.00%

                      • 1.49

                      • MFS Investment Management K.K.

                      •  

                        84,061,357

                      • -2.09%

                      • 1.32

                      • T. Rowe Price Associates, Inc.

                      •  

                        83,709,399

                      • -20.32%

                      • 1.31

                      • Pfizer Savings Plan

                      •  

                        67,339,776

                      • +15.91%

                      • 0.83

                      • State Farm Mutual Automobile Ins CO

                      •  

                        60,607,997

                      • 0.00%

                      • 0.95

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Drug Manufacturers – Major

                      Type

                      Slow Growth

                      Style

                      Large Value

                      Pfizer Inc was incorporated under the laws of the State of Delaware on June 2, 1942. It is a research-based, biopharmaceutical company. The Company applies science and its global resources to bring therapies to people that extend and...more improve their lives through the discovery, development and manufacture of healthcare products. The Company’s portfolio includes medicines and vaccines, as well as many of the world’s known consumer healthcare products. They managed its operations through four operating segments-Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; and Consumer Healthcare. Primary Care operating segment-included revenues from prescription pharmaceutical products primarily prescribed by primary-care physicians, and included products in the following therape...moreutic and disease areas: Alzheimer’s disease, cardiovascular (excluding pulmonary arterial hypertension), erectile dysfunction, and genitourinary, major depressive disorder, and pain, respiratory and smoking cessation. Specialty Care and Oncology operating segment-was comprised of the Specialty Care business unit and the Oncology business unit. Established Products segment included revenues from prescription pharmaceutical products that had lost patent protection or marketing exclusivity in certain countries and/or regions. Emerging Markets-included revenues from all prescription pharmaceutical products sold in emerging markets, including Asia excluding Japan and South Korea, Latin America, the Middle East, Eastern Europe, Africa, Turkey and Central Europe. Consumer Healthcare operating segment-includes worldwide revenues from non-prescription products in the following therapeutic categories: dietary supplements, pain management, respiratory and personal care. In 2013, products marketed by Consumer Healthcare included Advil, Caltrate, Centrum, ChapStick, Emergen-C, Preparation H and Robitussin. In its global biopharmaceutical businesses, they promote its products to healthcare providers and patients. The Company also markets directly to consumers in the U.S. through direct-to-consumer advertising that communicates the approved uses, benefits and risks of its products while motivating people to have meaningful conversations with their doctors. Its biotechnology products, including BeneFIX, ReFacto, Xyntha, Enbrel and the Prevnar family, may face competition in the future from biosimilars. The Company competes with other companies that manufacture and sell products that treat diseases or indications similar to those treated by its major products. The Company is subject to extensive regulation by national, state and local agencies in the countries in which they do business.lessless

                      Key People

                      Ian C. Read

                      CEO/Chairman of the Board/Director

                      Frank A. D'Amelio

                      CFO/Executive VP, Divisional

                      Sally Susman

                      Executive VP, Divisional

                      Dr. Freda C. Lewis-Hall,M.D.

                      Chief Medical Officer/Executive VP

                      Douglas M. Lankler

                      Executive VP/General Counsel

                      • Pfizer Inc

                      • 235 East 42nd Street

                      • New York, NY 10017-5755

                      • USA.Map

                      • Phone: +1 212 733-2323

                      • Fax: -

                      • pfizer.com

                      Incorporated

                      1942

                      Employees

                      77,700

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: